Galectin Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Galectin Therapeutics's total funding is $18.5M.
- Galectin Therapeutics has 45 Employees.
- Galectin Therapeutics currently has 1 job openings.
What Is Galectin Therapeutics?
Pro-Pharmaceuticals is a drug development company commercializing a new generation of anti-cancer treatments using carbohydrate molecules to significantly upgrade the safety and efficacy of standard cancer agents. Trading under the symbol PROH.OB, the company is headquartered in Newton, Mass., and was founded in 2000.keywords:N/A